Home › Impact Of Merck Litigation On Ionis Pharmaceuticals
 

Keywords :   


Impact Of Merck Litigation On Ionis Pharmaceuticals

2016-03-24 10:32:22| Biotech - Topix.net

Ionis has the cash necessary to advance its pipeline, so it is not necessarily reliant upon a verdict with Gilead in order to meet targets. The much watched litigation between Gilead Sciences and Merck appears as though it is rapidly heading towards a jury verdict.

Tags: impact litigation pharmaceuticals merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Who is Paula Vennells? Ex-Post Office boss in Horizon IT inquiry
16.05EU sees significant increase in African swine fever outbreaks in 2023
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05INDA Releases 11th Annual North America Supply Report
16.05Dow and SCGC Partner to Change 200KTA of Plastic Waste Into Circular Products
16.05Leanpath Uses Generative AI to Drive Action on Food Waste Data
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
16.05ECONWARDs Counterplan for Landfill-Bound Organics
More »